Editorial
T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
Abstract
T1G3 bladder cancer is an unpredictable beast and remains a controversial topic within the urology community. The optimal treatment strategy is a hotly contested subject; in responders, maintenance intravesical instillations of bacillus Calmette-Guerin (BCG) and close endoscopic management offers adequate cancer control with a bladder sparing approach.